These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34480041)

  • 1. Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study.
    Al Sulaiman K; Aljuhani O; Saleh KB; Badreldin HA; Al Harthi A; Alenazi M; Alharbi A; Algarni R; Al Harbi S; Alhammad AM; Vishwakarma R; Aldekhyl S
    Sci Rep; 2021 Sep; 11(1):17648. PubMed ID: 34480041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.
    Al Sulaiman K; Aljuhani O; Al Dossari M; Alshahrani A; Alharbi A; Algarni R; Al Jeraisy M; Al Harbi S; Al Katheri A; Al Eidan F; Al Bekairy AM; Al Qahtani N; Al Muqrin M; Vishwakarma R; Al Ghamdi G
    Crit Care; 2021 Jun; 25(1):223. PubMed ID: 34193235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study.
    Al Sulaiman K; Aljuhani O; Al Shaya AI; Kharbosh A; Kensara R; Al Guwairy A; Alharbi A; Algarni R; Al Harbi S; Vishwakarma R; Korayem GB
    Crit Care; 2021 Oct; 25(1):363. PubMed ID: 34663411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
    Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Badreldin HA; Alsalloum MA; Eljaaly K; Alharbi A; Aljehani R; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Al Aamer K; Al Enazi H; Almusallam M; Alshehri A; Bukhari R; Alasmari G; AlQahtani MM; Al Shammari S; Alsulaymi HO; Al Sulaiman K
    J Intensive Care Med; 2023 Jun; 38(6):534-543. PubMed ID: 36683420
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
    Al Harthi AF; Aljuhani O; Korayem GB; Altebainawi AF; Alenezi RS; Al Harbi S; Gramish J; Kensara R; Hafidh A; Al Enazi H; Alawad A; Alotaibi R; Alshehri A; Alhuthaili O; Vishwakarma R; Bin Saleh K; Alsulaiman T; Alqahtani RA; Hussain S; Almazrou S; Al Sulaiman K
    J Intensive Care Med; 2022 Sep; 37(9):1238-1249. PubMed ID: 35450493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study.
    Aljuhani O; Al Sulaiman K; Korayem GB; Altebainawi AF; Alsohimi S; Alqahtani R; Alfaifi S; Alharbi A; AlKhayrat A; Hattan A; Albassam M; Almohammed OA; Alkeraidees A; Alonazi DA; Alsalman WF; Aldamegh G; Alshahrani R; Vishwakarma R
    Sci Rep; 2024 Feb; 14(1):3037. PubMed ID: 38321099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of methylprednisolone in COVID-19 patients: A propensity score matched retrospective cohort study.
    You X; Wu CH; Fu YN; He Z; Huang PF; Chen GP; Lin CH; Ming WK; Lin RF
    PLoS One; 2020; 15(12):e0244128. PubMed ID: 33382734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Outcomes and Process of Care for Patients Treated at Hospitals Dedicated for COVID-19 Care vs Other Hospitals.
    Bergman ZR; Usher M; Olson A; Chipman JG; Brunsvold ME; Beilman G; Tignanelli C; Lusczek ER
    JAMA Netw Open; 2022 Mar; 5(3):e220873. PubMed ID: 35238935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of corticosteroid doses on prognosis of severe and critical COVID-19 patients with Omicron variant infection: a propensity score matching study.
    Wang S; Chen Z; Zhang X; Wu X; Wang Y; Zhang Q; Huang L; Cui X; Cai Y; Huang X; Xia J; Gu S; Li M; Zhan Q
    Inflammopharmacology; 2024 Oct; 32(5):3347-3356. PubMed ID: 39120772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database.
    Wu Z; Li H; Liao K; Wang Y
    J Surg Res; 2021 Jul; 263():89-101. PubMed ID: 33639374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia.
    Mutair AA; Shamou J; Alhumaid S; Layqah L; Ahmed GY; Thoyaja K; Mohaini MA; Almahmoud S; Barry M; Khan A; Dhama K; Al-Jamea LH; Woodman A; Rabaan AA
    J Infect Public Health; 2022 Apr; 15(4):389-394. PubMed ID: 35299062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study.
    Ikeda S; Misumi T; Izumi S; Sakamoto K; Nishimura N; Ro S; Fukunaga K; Okamori S; Tachikawa N; Miyata N; Shinkai M; Shinoda M; Miyazaki Y; Iijima Y; Izumo T; Inomata M; Okamoto M; Yamaguchi T; Iwabuchi K; Masuda M; Takoi H; Oyamada Y; Fujitani S; Mineshita M; Ishii H; Nakagawa A; Yamaguchi N; Hibino M; Tsushima K; Nagai T; Ishikawa S; Ishikawa N; Kondoh Y; Yamazaki Y; Gocho K; Nishizawa T; Tsuzuku A; Yagi K; Shindo Y; Takeda Y; Yamanaka T; Ogura T
    Sci Rep; 2021 May; 11(1):10727. PubMed ID: 34021229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of non-COVID-19 critically ill patients during the COVID-19 pandemic : A retrospective propensity score-matched analysis.
    Bologheanu R; Maleczek M; Laxar D; Kimberger O
    Wien Klin Wochenschr; 2021 Sep; 133(17-18):942-950. PubMed ID: 33909109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
    Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
    Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study.
    Alharthy A; Aletreby W; Faqihi F; Balhamar A; Alaklobi F; Alanezi K; Jaganathan P; Tamim H; Alqahtani SA; Karakitsos D; Memish ZA
    J Epidemiol Glob Health; 2021 Mar; 11(1):98-104. PubMed ID: 33095982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxycycline's Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study.
    Al Sulaiman K; Aljuhani O; Korayem GB; Alnajjar LI; Altebainawi AF; AlFaifi M; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Alsowaida YS; Alsohimi S; Almagthali A; Alay SM; Altaher N; Alamri MG; Alangari D; Alzahrani A; Abdul Razack HI; Alhamoud J; Alshaya A; Gramish J; Al Aamer K; Alsaeedi AS; Alghamdi G
    Clin Appl Thromb Hemost; 2023; 29():10760296231177017. PubMed ID: 37322869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study.
    Al Harbi S; Kensara R; Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Vishwakarma R; Alenazi AM; Almutairi A; Alshaya O; Alraddadi S; Al Sulaiman T; Aldakkan L; Mahboob R; Alaamer K; Alissa A; Hafiz A; Aldhayyan N; Althewaibi S; Alenezi F; Alkhotani NY; Alghamdi SA; Alenazi AA; Al Sulaiman K
    Clin Appl Thromb Hemost; 2022; 28():10760296221103864. PubMed ID: 35658686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study.
    Al Sulaiman K; Aljuhani O; Alhammad AM; Al Aamer K; Alshehri S; Alhuwahmel A; Kharbosh A; Alshehri A; Alshareef H; Al Sulaihim I; Alghamdi A; Al Harbi S; Vishwakarma R; Alabdan N; Alrajhi Y; Al Katheri A; Alenazi AA; Alalawi M; Al Ghamdi G
    Saudi Pharm J; 2022 Dec; 30(12):1748-1754. PubMed ID: 36601502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.